Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Bottles of Lies PDF full book. Access full book title Bottles of Lies by Katherine Eban. Download full books in PDF and EPUB format.
Author: Katherine Eban Publisher: ISBN: 9789353450441 Category : Drug adulteration Languages : en Pages : 0
Book Description
"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?"--Dust jacket.
Author: Katherine Eban Publisher: ISBN: 9789353450441 Category : Drug adulteration Languages : en Pages : 0
Book Description
"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?"--Dust jacket.
Author: Katherine Eban Publisher: HarperCollins ISBN: 0063054108 Category : Medical Languages : en Pages : 523
Book Description
A NEW YORK TIMES BESTSELLER * New York Times Notable Book * Best Book of the Year: New York Public Library, Kirkus Reviews, Science Friday With a new postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
Author: Bhupesh Bhandari Publisher: Penguin Global ISBN: Category : Business & Economics Languages : en Pages : 262
Book Description
It Took A Sleeping Pill A Get A Somnolent Company Up And Running. The Drug Was Calmpose Ranbaxy S Answer To Roche S Valium And Its Launch In 1969 Was The Hitherto Unknown Company S First Step On The Long Road To Global Stardom. India Accounts For A Tiny Fraction Of The World Pharmaceuticals Market Just 1.2 Per Cent. To Become Really Big, Ranbaxy Realized Early In Life, It Had To Go Global. But Success Doesn T Come Easy In The World Market Which Is Dominated By Players Like Pfizer, Novartis And Glaxosmithkline. With Each Of These Putting Billions Of Dollars Into Research Every Year, It Takes A Great Deal Of Courage And Wisdom To Venture Into Their Territory Markets Like The United States And Europe. The Ranbaxy Story Sets Down, For The First Time, Ranbaxy S Remarkable Journey From A Distributor Of Medicine To A Multinational Corporation, Deriving Over Eighty Per Cent Of Its Business From Outside India. It Is Also The Story Of The Singh Family, Of Bhai Mohan Singh S Dogged Pursuit To Expand The Company During The Licence-Permit-Quota Raj And Of Dr Parvinder Singh Who Was Convinced Way Back In The 1970S That Ranbaxy S Destiny Lay In The International Markets. Bhupesh Bhandari, A Business Journalist Who Has Followed The Company Closely For Over A Decade, Traces Ranbaxy S Growth Against The Backdrop Of The Global Pharmaceutical Business. What Ensues Is A Riveting Account Of Human Ambition And Corporate Strategies In This Intimate Portrayal Of One Company S Rise To Success.
Author: Soma Das Publisher: Portfolio ISBN: 9780670088577 Category : Biography & Autobiography Languages : en Pages : 520
Book Description
NOMINATED FOR TATA LITERATURE LIVE AWARDS AND SHORTLISTED FOR GAJA CAPITAL BEST BUSINESS BOOK PRIZE The book is an untold human story of an enterprise and its creator, Dilip Shanghvi, who raced ahead of Mukesh Ambani to become the richest Indian in 2015 Shanghvi is one of the most interesting and least understood business minds of India whose journey has been shrouded in mystery because of his reticence. The book reveals the riveting story of the fiercely intense personality that lies beneath his calm demeanour. Based on interviews with over 150 friends, family members, rivals, former aides and Shanghvi himself, it traces his transformation from a quiet, curious child working in his father's small shop to an astute strategist, who built India's largest pharma company, Sun Pharma, despite being untrained in science. The tale unravels his contrarian and controversial bets that made Sun a global force, and him a 'turn-around' artist. It is also about the friends and family Shanghvi started his company with, the hurt and emotional conflicts surrounding their separation, and how Shanghvi staked his closest relationships to professionalize Sun. This book is an extraordinary story of an ordinary man, who chooses to stay anti-famous. He would rather have his face unrecognized, his story untold. But at a time, when a billion dreams are simmering in an aspiring India, this tale is for everyone who has once had a secret dream, an insanely bold one.
Author: K Anji Reddy Publisher: Penguin UK ISBN: 935118921X Category : Business & Economics Languages : en Pages : 333
Book Description
From his birth in a village in Andhra to founding and running Dr. Reddy’s Laboratories, now one of India’s largest pharmaceutical enterprises, Dr K. Anji Reddy’s journey makes for an inspiring story. That story is told rivetingly in his own words in his memoir, An Unfinished Agenda. Dr Anji Reddy became an entrepreneur at a time when India was woefully short of technology to manufacture many basic medicines. Then, in barely three decades, the Indian pharmaceutical industry had grown to the point that India not only became self-sufficient in medicine, but also a supplier of affordable generic medicines to the world. Dr Anji Reddy provides a ringside view of this remarkable transformation, with fascinating anecdotes about those who made it happen. The history of modern medicine is a gripping story of triumphs and failures. An Unfinished Agenda takes the reader on a whirlwind tour of the science of medicine over the last hundred years and reminds us of the stark challenges that remain.
Author: Pankaj Sekhsaria Publisher: Routledge ISBN: 0429831323 Category : Technology & Engineering Languages : en Pages : 198
Book Description
Instrumental Lives is an account of instrument making at the cutting edge of contemporary science and technology in a modern Indian scientific laboratory. For a period of roughly two-and-half decades, starting the late 1980s, a research group headed by CV Dharmadhikari in the physics department at the Savitribai Phule University, Pune, fabricated a range of scanning tunnelling and scanning force microscopes including the earliest such microscopes made in the country. Not only were these instruments made entirely in-house, research done using them was published in the world's leading peer reviewed journals, and students who made and trained on them went on to become top class scientists in premier institutions. The book uses qualitative research methods such as open-ended interviews, historical analysis and laboratory ethnography that are standard in Science and Technology Studies (STS), to present the micro-details of this instrument making enterprise, the counter-intuitive methods employed, and the unexpected material, human and intellectual resources that were mobilised in the process. It locates scientific research and innovation within the social, political and cultural context of a laboratory's physical location and asks important questions of the dominant narratives of innovation that remain fixated on quantitative metrics of publishing, patenting and generating commerce. The book is a story as much of the lives of instruments and their deaths as it is of the instrumentalities that make those lives possible and allow them to live on, even if with a rather precarious existence.
Author: Penguin Books India Publisher: Penguin UK ISBN: 9352140214 Category : Business & Economics Languages : en Pages : 325
Book Description
How did Dhirubhai Ambani build a polyester plant in record time? What made JRD Tata launch India’s first airline? How did Vijay Mallya wrest control of Shaw Wallace from Manu Chhabria? Why did Bhai Mohan Singh fall out with his favourite son and lose control of Ranbaxy? The Portfolio Book of Great Indian Business Stories contains excerpts from a selection of the finest business books published by Penguin Portfolio. This anthology features snippets from the lives of some of the most eminent business leaders India has seen—M.S. Oberoi, Ratan Tata, Aditya Birla and Rahul Bajaj, among others. There are tales of outstanding successes, crushing failures, extraordinary challenges and relentless determination, some of which chronicle the times when these legends were just simple businessmen trying to make a mark. The grit and ruthless persistence of these men defined who they were and the legacies they left behind.
Author: Dan Davies Publisher: Scribner ISBN: 1982114932 Category : True Crime Languages : en Pages : 304
Book Description
An entertaining, deeply informative explanation of how high-level financial crimes work, written by an industry insider who’s an expert in the field. The way most white-collar crime works is by manipulating institutional psychology. That means creating something that looks as much as possible like a normal set of transactions. The drama comes later, when it all unwinds. Financial crime seems horribly complicated, but there are only so many ways you can con someone out of what’s theirs. In Lying for Money, veteran regulatory economist and market analyst Dan Davies tells the story of fraud through a genealogy of financial malfeasance, including: the Great Salad Oil swindle, the Pigeon King International fraud, the fictional British colony of Poyais in South America, the Boston Ladies’ Deposit Company, the Portuguese Banknote Affair, Theranos, and the Bre-X scam. Davies brings new insights into these schemes and shows how all frauds, current and historical, belong to one of four categories (“long firm,” counterfeiting, control fraud, and market crimes) and operate on the same basic principles. The only elements that change are the victims, the scammers, and the terminology. Davies has years of experience picking the bones out of some of the most famous frauds of the modern age. Now he reveals the big picture that emerges from their labyrinths of deceit and explains how fraud has shaped the entire development of the modern world economy.
Author: Aihwa Ong Publisher: Duke University Press ISBN: 0822393204 Category : Social Science Languages : en Pages : 345
Book Description
Providing the first overview of Asia’s emerging biosciences landscape, this timely and important collection brings together ethnographic case studies on biotech endeavors such as genetically modified foods in China, clinical trials in India, blood collection in Singapore and China, and stem-cell research in Singapore, South Korea, and Taiwan. While biotech policies and projects vary by country, the contributors identify a significant trend toward state entrepreneurialism in biotechnology, and they highlight the ways that political thinking and ethical reasoning are converging around the biosciences. As ascendant nations in a region of postcolonial emergence, with an “uncanny surplus” in population and pandemics, Asian countries treat their populations as sources of opportunity and risk. Biotech enterprises are allied to efforts to overcome past humiliations and restore national identity and political ambition, and they are legitimized as solutions to national anxieties about food supplies, diseases, epidemics, and unknown biological crises in the future. Biotechnological responses to perceived risks stir deep feelings about shared fate, and they crystallize new ethical configurations, often re-inscribing traditional beliefs about ethnicity, nation, and race. As many of the essays in this collection illustrate, state involvement in biotech initiatives is driving the emergence of “biosovereignty,” an increasing pressure for state control over biological resources, commercial health products, corporate behavior, and genetic based-identities. Asian Biotech offers much-needed analysis of the interplay among biotechnologies, economic growth, biosecurity, and ethical practices in Asia. Contributors Vincanne Adams Nancy N. Chen Stefan Ecks Kathleen Erwin Phuoc V. Le Jennifer Liu Aihwa Ong Margaret Sleeboom-Faulkner Kaushik Sunder Rajan Wen-Ching Sung Charis Thompson Ara Wilson
Author: K.L. Sharma Publisher: Notion Press ISBN: 1639403566 Category : Medical Languages : en Pages : 251
Book Description
Indian pharmaceutical industry, it is argued, has democratized the availability, accessibility and affordability of medicines. Everyone, rich or poor, can now get them at a fraction of the cost of branded drugs. However, the allegations about their suspect quality, if true, pose questions of life-and-death for the unsuspecting consumers. Is it the messiah supplying the low-cost quality medicines across the globe or is it the precursor for the ultimate indigence of the unsuspecting millions consuming poor-quality generic medicines? In the absence of any evidence, it remains an inexplicable enigma. This book by a public policy practitioner of four decades who steered drug regulation in the Government of India unravels the truth.
Author: Katherine Eban
Author: Katherine Eban
Author: Katherine Eban
Author: Bhupesh Bhandari
Author: Soma Das
Author: K Anji Reddy
Author: Pankaj Sekhsaria
Author: Penguin Books India
Author: Dan Davies
Author: Aihwa Ong
Author: K.L. Sharma